To uncover the molecular mechanism of CD9-mediated promotion of tumor growth in PDAC, AP-MS was carried out to identify the CD9 interactome, and glutamine transporter ASCT2 (also named SLC1A5) was among the top hits (42). The gene discussed is CD9; the disease is neoplasm.